20 years of DNA damage signaling to p53

25 Years of p53 Research

Volumn , Issue , 2005, Pages 53-71

  McLure, Kevin G ^a   Kastan, Michael B ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84919683624     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-2922-6_3     Document Type: Chapter

References (137)

1. Ahn, J.-Y., Schwarz, J. K., Piwnica-Worms, H., and Canman, C. E. (2000). Threonine 68 phosphorylation by ATM is required for efficient activation of Chk2 in response to ionizing radiation. Cancer Research 60, 5934-5936.
2. Arai, N., Nomura, D., Yokota, K., Wolf, D., Brill, E., Shohat, O., and Rotter, V. (1986). Immunologically distinct p53 molecules generated by alternative splicing. Mol Cell Biol 6, 3232-3239.
3. Bakalkin, G., Yakovleva, T., Selivanova, G., Magnusson, K. P., Szekely, L., Kiseleva, E., Klein, G., Terenius, L., and Wiman, K. G. (1994). p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci USA 91, 413-417.
4. Bakkenist, C. J. and Kastan, M. B. (2003). DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499-506.
5. Balagurumoorthy, P., Sakamoto, H., Lewis, M. S., Zambrano, N., Clore, G. M., Gronenborn, A. M., Appella, E., and Harrington, R. E. (1995). Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. Proc Natl Acad Sci USA 92, 8591-8595.
6. Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., and Ziv, Y. (1998). Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281, 1674-1677.
7. Canman, C. E., Gilmer, T., Coutts, S., and Kastan, M. B. (1995). Growth factor modulation of p53-mediated growth arrest vs. apoptosis. Genes Dev. 9, 600-611.
8. Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D. (1998). Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281, 1677-1679.
9. Canman, C. E., Wolff, A. C., Chen, C., Fornace, A. J., and Kastan, M. B. (1994). The p53-dependent G1 Cell Cycle Checkpoint Pathway and Ataxia-Telangiectasia. Cancer Res 54, 5054-5058.
10. Cao, L., Li, W., Kim, S., Brodie, S. G., and Deng, C. X. (2003). Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. Genes Dev. 17, 201-213.
11. Chao, C., Saito, S., Anderson, C. W., Appella, E., and Xu, Y. (2000). Phosphorylation of murine p53 at Ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci USA 97, 11936-11941.
12. Chehab, N. H., Malikzay, A., Stavridi, E. S., and Halazonetis, T. D. (1999). Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 96, 13777-13782.
13. Cho, Y., Gorina, S., Jeffery, P. D., and Pavletich, N. P. (1994). Crystal structure of a p53 tumor suppressor-DNA complex: Understanding tumorigenic mutations. Science 265, 346-355.
14. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852.
15. D'Orazi, G., Cecchinelli, B., Bruno, T., Manni, I., Higashimoto, Y., Saito, S., Gostissa, M., Coen, S., Marchetti, A., Del Sal, G., Piaggio, G., Fanciulli, M., Appella, E., and Soddu, S. (2002). Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 4, 11-9.
16. Davison, T. S., Vagner, C., Kaghad, M., Ayed, A., Caput, D., and Arrowsmith, C. H. (1999). p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274, 18709-18714.
17. Deleo, A. B., Jay, G., Appells, E., Dubois, G. C., Law, L. W., and Old, L. J. (1979). Detection of a transformation-related antigen in chemically induced sarcomas and other transfromed cells of the mouse. Proc Natl Acad Sci USA 76, 2420-2424.
18. Di Leonardo, A., Linke, S. P., Clarkin, K., and Wahl, G. M. (1994). DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540-2551.
19. Dornan, D. and Hupp, T. R. (2001). Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300. EMBO Rep 2, 139-144.
20. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tlsty, T. D., Lees, E., Harper, W., Elledge, S. J., and Reed, S. I. (1994). p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76, 1013-1023.
21. Dumaz, N. and Meek, D. W. (1999). Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18, 7002-7010.
22. Dumaz, N., Milne, D. M., and Meek, D. W. (1999). Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Letters 463, 312-316.
23. Durell, S. R., Appella, E., Nagaich, A. K., Harrington, R. E., Jernigan, R. L., and Zhurkin, V. B. (1998). DNA bending induced by tetrameric binding of the tumor-suppressive p53 protein: steric constraints on conformation. In Macromolecules, proc. structure, motion, interactions and expression of biological of the tenth conversation, R. H. Sarma and M. H. Sarma, eds. (Albany, NY: Adenine Press), pp. 277-295.
24. El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., and Vogelstein, B. (1992). Definition of a consensus binding site for p53. Nature 356, 215-221.
25. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
26. Espinosa, J. M. and Emerson, B. M. (2001). Transcriptional regulation by p53 through intrinsic DNA/chromatin binding and site-directed cofactor recruitment. Mol Cell 8, 57-69.
27. Fei, P., Bernhard, E. J., and El-Deiry, W. S. (2002). Tissue-specific induction of p53 targets in vivo. Cancer Res. 62, 7316-7327.
28. Flores, E. R., Tsai, K. Y., Crowley, D., Sengupta, S., Yang, A., McKeon, F., and Jacks, T. (2002). p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416, 560-564.
29. Friedberg, E. C. (2003). DNA damage and repair. Nature 421, 436-440.
30. Fu, L. and Benchimol, S. (1997). Participation of the human p53 3'UTR in translational repression and activation following y-irradiation. EMBO J 16, 4117-4125.
31. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., and Shay, J. W. (1992). A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 12, 2866-2871.
32. Galmarini, C. M., Voorzanger, N., Falette, N., Jordheim, L., Cros, E., Puisieux, A., and Dumontet, C. (2003). Influence of p53 and p21 (WAF1) expression on sensitivity of cancer cells to cladribine. Biochem Pharmacol 65, 121-129.
33. Giaccia, A. J. and Kastan, M. B. (1998). The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12, 2973-2983.
34. Gorina, S. and Pavletich, N. P. (1996). Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274, 1001-1005.
35. Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M., and Del Sal, G. (1999). Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 18, 6462-6471.
36. Grossman, S. R., Deato, M. E., Brignone, C., Chan, H. M., Kung, A. L., Tagami, H., Nakatani, Y., and Livingston, D. M. (2003). Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300, 342-344.
37. Gu, W. and Roeder, R. G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
38. Guo, Z., Kumagai, A., Wang, S. X., and Dunphy, W. G. (2000). Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts. Genes Dev. 14, 2745-2756.
39. Gupta, M., Fan, S., Zhan, Q., Kohn, K. W., O'Connor, P. M., and Pommier, Y. (1997). Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. Clinical Cancer Research 3, 1653-1660.
40. Halazonetis, T. D. and Kandil, A. N. (1993). Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants. EMBO J 12, 5057-5064.
41. Han. Z., Wei, W., Dunaway, S., Darnowski, J. W., Calabresi, P., Sedivy, J., Hendrickson, E. A., Balan, K. V., Pantazis, P., and Wyche, J. H. (2002). Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J. Biol. Chem. 277, 17154-17160.
42. Hartwell, L. H. and Weinert, T. A. (1989). Checkpoints: Controls that ensure the order of cell cycle enents. Science 246, 629-634.
43. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
44. Hirao, A., Kong, Y.-Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., and Mak, T. W. (2000). DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287, 1824-1827.
45. Hofmann, T. G., Moller, A., Sirma, H., Zentgraf, H., Taya, Y., Droge, W., Will, H., and Schmitz, M. L. (2002). Regulation of p53 activity by its interaction with homeodomaininteracting protein kinase-2. Nat Cell Biol 4, 1-10.
46. Honda, R., Tanaka, H., and Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters 420, 25-27.
47. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. (1992). Regulation of the specific DNA binding function of p53. Cell 71, 875-886.
48. Hupp, T. R., Sparks, A., and Lane, D. P. (1995). Small peptides activate the latent sequencespecific DNA binding function of p53. Cell 83, 237-245.
49. Ito, A., Kawaguchi, Y., Lai, C. H., Kovacs, J. J., Higashimoto, Y., Appella, E., and Yao, T. P. (2002). MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 21, 6236-6245.
50. Ito, A., Lai, C. H., Zhao, X., Saito, S., Hamilton, M. H., Appella, E., and Yao, T. P. (2001). p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 20, 1331-1340.
51. Jayaraman, L., Murthy, K. G. K., Zhu, C., Curran, T., Xanthoudakis, S., and Prives, C. (1997). Identification of redox-repair protein Ref-1 as a potent activator of p53. Genes Dev. 11, 558-570.
52. Jayaraman, L. and Prives, C. (1995). Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81, 1021-1029.
53. Jimenez, G. S., Bryntesson, F., Torres-Arzayus, M. I., Priestley, A., Beeche, M., Saito, S., Sakaguchi, K., Appella, E., Jeggo, P. A., Tacciolo, G. E., Wahl, G. M., and Hubank, M. (1999). DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 400, 81-83.
54. Kaeser, M. D. and Iggo, R. D. (2002). Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci USA 99, 95-100.
55. Kapoor, M. and Lozano, G. (1998). Functional activation of p53 via phosphorylation following DNA damage by UV but not y radiation. Pro Natl Acad Sci USA 95, 2834-2837.
56. Kastan, M. B. and Kuerbitz, S. J. (1993). Control of G1 arrest after DNA damage. Environ. Health Persp. 101(suppl 5), 55-58.
57. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51, 6304-6311.
58. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71, 587-597.
59. Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C., and Vogelstein, B. (1991). Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711.
60. Khan, S. H. and Wahl, G. M. (1998). p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest. Cancer Res 58, 396-401.
61. Khanna, K. K. and Lavin, M. F. (1993). Ionizing Radiation and UV induction of p53 protein by different pathways in ataxia-telangiectasia cells. Oncogene 8, 3307-3312.
62. Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., and Gudkov, A. V. (1999). A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285, 1733-1737.
63. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
64. Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., and Pavletich, N. P. (1996). Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274, 948-953.
65. Lane, D. P. and Crawford, L. V. (1979). T antigen is bound to host protein in SV40 transformed cells. Nature 278, 261-263.
66. Lee, E. J., Gerhold, M., Palmer, M. W., and Christen, R. D. (2003). p53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection. Br. J. Cancer 88, 754-759.
67. Lee, S., Elenbaas, B., Levine, A., and Griffith, J. (1995). p53 and its 14kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81, 1013-1020.
68. Lee, S. J., Dimtchev, A., Lavin, M., Dritschilo, A., and Jung, M. (1998). A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-kB. Oncogene 17, 1821-1826.
69. Lees-Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., and Anderson, C. W. (1992). Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53. Mol Cell Biol 12, 5041-5049.
70. Lin. J., Blake, M., Tang, C., Zimmer, D., Rustandi, R. R., Weber, D. J., and Carrier, F. (2001). Inhibition of p53 transcriptional activity by the S100B calcium-binding protein. J. Biol. Chem. 276, 35037-35041.
71. Linzer, D. I. and Levine, A. J. (1979). Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17, 43-52.
72. Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., De Mayo, F., Bradley, A., Donehower, L. A., and Elledge, S. J. (2000). Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev 14, 1448-1459.
73. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. (1992). Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70, 923-935.
74. Lowe, S. W., Schmitt, S. W., Smith, S. W., Osborne, B. A., and Jacks, T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362, 847-849.
75. Lu, H., Taya, Y., Ikeda, M., and Levine, A. J. (1998). Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc Natl Acad Sci USA 95, 6399-6402.
76. Magrini, R., Bhonde, M. R., Hanski, M. L., Notter, M., Scherubl, H., Boland, C. R., Zeitz, M., and Hanski, C. (2002). Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status. Int J Cancer 101, 23-31.
77. Maki, C. G. and Howley, P. M. (1997). Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol Cell Biol 17, 355-363.
78. Maltzman, W. and Czyzyk, L. (1984). UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4(9), 1689-1694.
79. Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., and Elledge, S. J. (2000). Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci USA 97, 10389-10394.
80. Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., Kastan, M. B., Katzir, E., and Oren, M. (2001). ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15, 1067-1077.
81. Mazan-Mamczarz, K., Galban, S., Lopez de Silanes, I., Martindale, J. L., Atasoy, U., Keene, J. D., and Gorospe, M. (2003). RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA 100, 8354-8359.
82. McLure, K. G. and Lee, P. W. K. (1998). How p53 binds DNA as a tetramer. EMBO J 17, 3342-3350.
83. Melchionna, R., Chen, X.-B., Blasina, A., and McGowan, C. H. (2000). Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1. Nature Cell Biol 2, 762-765.
84. Middeler, G., Zerf, K., Jenovai, S., Thulig, A., Tschodrichrotter, M., Kubitscheck, U., and Peters, R. (1997). The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14, 1407-1417.
85. Midgley, C. A. and Lane, D. P. (1997). p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding. Oncogene 15, 1179-1189.
86. Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., and Moll, U. M. (2003). p53 has a direct apoptogenic role at the mitochondria. Mol Cell 11, 577-590.
87. Momand, J., Zambetti, G. P., Olson, D. C., George, D. L., and Levine, A. J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69, 1237-1245.
88. Morozov, V. E., Falzon, M., Anderson, C. W., and Kuff, E. L. (1994). DNA-dependent protein kinase is activated by nicks and larger single-stranded gaps. J. Biol. Chem. 269, 16684-16688.
89. Nicholls, C. D., McLure, K. G., Shields, M. A., and Lee, P. W. (2002). Biogenesis of p53 involves cotranslational dimerization of monomers and posttranslational dimerization of dimers. Implications on the dominant negative effect. J. Biol. Chem. 277, 12937-12945.
90. Nichols, N. M. and Matthews, K. S. (2002). Human p53 phosphorylation mimic, S392E, increases nonspecific DNA affinity and thermal stability. Biochemistry 41, 170-178.
91. Nie, Y., Li, H.-H., Bula, C. M., and Liu, X. (2000). Stimulation of p53 DNA binding by c-Abl requires the p53 C terminus and tetramerization. Mol Cell Biol 20, 741-748.
92. Offer, H., Wolkowicz, R., Matas, D., Blumenstein, S., Livneh, A., and Rotter, V. (1999). Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. FEBS Letters 450, 197-204.
93. Okorokov, A. L., Ponchel, F., and Milner, J. (1997). Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53. EMBO J 16, 6008-6017.
94. Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, B. (1993). Oncoprotein mdm2 conceals the activation domain of tumor suppressor p53. Nature 362, 857-860.
95. Pestina, T. I., Cleveland, J. L., Yang, C., Zambetti, G. P., and Jackson, C. W. (2001). Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis. Blood 98, 2084-2090.
96. Phelps, M., Darley, M., Primrose, J. N., and Blaydes, J. P. (2003). p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells. Cancer Res. 63, 2616-2623.
97. Reed, M., Woelker, B., Wang, P., Wang, Y., Anderson, M. E., and Tegrmeyer, P. (1995). The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc Natl Acad Sci USA 92, 9455-9459.
98. Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., McMahon, M., Oren, M., and McCormick, F. (2000). Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103, 321-330.
99. Rodriguez, M. S., Desterro, J. M. P., Lain, S., Midgley, C. A., Lane, D. P., and Hay, R. T. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J 18, 6455-6461.
100. Rouse, J. and Jackson, S. P. (2002). Interfaces between the detection, signaling, and repair of DNA damage. Science 297, 547-551.
101. Rubbi, C. P. and Milner, J. (2003a). Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22, 6068-6077.
102. Rubbi, C. P. and Milner, J. (2003b). p53 is a chromatin accessibility factor for nucleotide excision repair of DNA damage. EMBO J 22, 975-986.
103. Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12, 2831-2841.
104. Sakaguchi, K., Saito, S., Higashimoto, Y., Roy, S., Anderson, C. W., and Appella, E. (2000). Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase. Effect on Mdm2 binding. J Biol Chem 275, 9278-9283.
105. Samuels-Lev, Y., O'Connor, D. J., Bergamaschi, D., Trigiante, G., Hsieh, J.-K., Zhong, S., Campargue, I., Naumovski, L., Crook, T., and Lu, X. (2001). ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8, 781-794.
106. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S., and Shiloh, Y. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268, 1749-1753.
107. Shieh, S.-Y., Ikeda, M., Taya, Y., and Prives, C. (1997). DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
108. Shieh, S.-Y., Taya, Y., and Prives, C. (1999). DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J 18, 1815-1823.
109. Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., and Kastan, M. B. (1997). DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev 11, 3471-3481.
110. Sluss, H. K., Armata, H., Gallant, J., and Jones, S. N. (2004). Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol Cell Biol 24, 976-984.
111. Stewart, Z. A., Leach, D. L., and Pietenpol, J. (1999a). p21 Waf1/Cip1 Inhibition of cyclin E/Cdk2 activity prevents endoreduplication after mitotic spindle disruption. Mol Cell Biol 19, 205-215.
112. Stewart, Z. A., Mays, D., and Pietenpol, J. A. (1999b). Defective G 1-S cell cycle checkpoint function sensitizes cells to microtubule inhibitor-induced apoptosis. Cancer Research 59, 3831-3837.
113. Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., and Wahl, G. M. (1999). A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J 18, 1660-1672.
114. Sturzbecher, H. W., Brain, R., Addison, C., Rudge, K., Remm, M., Grimaldi, M., Keenan, E., and Jenkins, J. R. (1992). A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene 7, 1513-1523.
115. Szak, S. T., Mays, D., and Pietenpol, J. A. (2001). Kinetics of p53 binding to promoter sites in vivo. Mol Cell Biol 21, 3375-3386.
116. Takenaka, I., Morin, F., Seizinger, B. R., and Kley, N. (1995). Regulation of the sequencespecific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270, 5405-5411.
117. Tao, W. and Levine, A. J. (1999). Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc Natl Acad Sci USA 96, 3077-3080.
118. Tibbetts, R. S., Brumbaugh, K. M., Williams, J. M., Sarkaria, J. N., Cliby, W. A., Shieh, S. Y., Taya, Y., Prives, C., and Abraham, R. T. (1999). A role for ATR in the DNA damageinduced phosphorylation of p53. Genes Dev. 13, 152-157.
119. Tishler, R. B., Calderwood, S. K., Coleman, C. N., and Price, B. D. (1993). Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53, 2212-2216.
120. Turenne, G. A., Paul, P., Laflair, L., and Price, B. D. (2001). Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene 20, 5100-5110.
121. Unger, T., Juven-Gershon, T., Moallem, E., Berger, M., Sionov, R. V., Lozano, G., Oren, M., and Haupt, Y. (1999). Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18, 1805-1814.
122. Unsal-Kacmaz, K. and Sancar, A. (2004). Quaternary structure of ATR and effects of ATRIP and replication protein A on its DNA binding and kinase activities. Mol Cell Biol 24, 1292-1300.
123. Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., and Wahl, G. M. (2002). c-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: a mechanism for oncogene-induced genetic instability. Mol Cell 9, 1031-1044.
124. Vaziri, C., Saxena, S., Jeon, Y., Lee, C., Murata, K., Machida, Y., Wagle, N., Hwang, D. S., and Dutta, A. (2003). A p53-dependent checkpoint pathway prevents rereplication. Mol Cell 11, 997-1008.
125. Wang, X., Zou, L., Zheng, H., Wei, Q., Elledge, S. J., and Li, L. (2003). Genomic instability and endoreduplication triggered by RAD17 deletion. Genes Dev. 17, 965-970.
126. Wang, Y., Schwedes, J. F., Parks, D., Mann, K., and Tegtmeyer, P. (1995). Interaction of p53 with its consensus DNA-binding site. Mol Cell Biol 15, 2157-2165.
127. Waterman, J. L., Shenk, J. L., and Halazonetis, T. D. (1995). The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. EMBO J 14, 512-519.
128. Waterman, M. J., Stavridi, E. S., Waterman, J. L. F., and Halazonetis, T. D. (1998). ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nature Genetics 19, 175.
129. Weinert, T. A. and Hartwell, L. H. (1988). The RAD9 gene controls the cell cycle response to DNA damage in saccharomyces cerevisiae. Science 241, 317-322.
130. Will, K., Warnecke, G., Bergmann, S., and Deppert, W. (1995). Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53. Nucleic Acids Res 23, 4023-4028.
131. Woo, R. A., Jack, M. T., Xu, Y., Burma, S., Chen, D. J., and Lee, P. W. (2002). DNA damageinduced apoptosis requires the DNA-dependent protein kinase, and is mediated by the latent population of p53. EMBO J 21, 3000-3008.
132. Woo, R. A., McLure, K. G., Lees-Miller, S. P., Rancourt, D. E., and Lee, P. W. K. (1998). DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature 394, 700-705.
133. Wu, X., Bayle, H., Olson, D., and Levine, A. J. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132.
134. Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., and Xu, Y. (2002). Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol. 22, 2441-2449.
135. Xanthoudakis, S., Miao, G., Wang, F., Pan, Y.-C. E., and Curran, T. (1992). Redox activation of Fos-Jun. DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11, 3323-3335.
136. Zhao, H. and Piwnica-Worms, H. (2001). ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol Cell Biol 21, 4129-4139.
137. Zhou, J., Ahn, J., Wilson, S. H., and Prives, C. (2001). A role for p53 in base excision repair. EMBO J 20, 914-923.